These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 1434130

  • 1. Effects of KW-3635, a novel dibenzoxepin derivative of a selective thromboxane A2 antagonist, on human, guinea pig and rat platelets.
    Miki I, Kishibayashi N, Nonaka H, Ohshima E, Takami H, Obase H, Ishii A.
    Jpn J Pharmacol; 1992 Jul; 59(3):357-64. PubMed ID: 1434130
    [Abstract] [Full Text] [Related]

  • 2. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A, Kawakage M, Shirakura S, Higo K, Kubo K, Ohshima E, Obase H.
    Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
    [Abstract] [Full Text] [Related]

  • 3. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
    Karasawa A, Shirakura S, Higo K, Kubo K.
    Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522
    [Abstract] [Full Text] [Related]

  • 4. Protective effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate against 9,11-dideoxy- 9 alpha, 11 alpha-epoxymethano-prostaglandin F2 alpha-induced sudden death in guinea-pigs and rats.
    Shirakura S, Karasawa A, Kubo K.
    Arzneimittelforschung; 1991 Dec; 41(12):1242-5. PubMed ID: 1815523
    [Abstract] [Full Text] [Related]

  • 5. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
    Miki I, Kase H, Ishii A.
    Eur J Pharmacol; 1992 Oct 01; 227(2):199-204. PubMed ID: 1426029
    [Abstract] [Full Text] [Related]

  • 6. Characterization of thromboxane A2/prostaglandin H2 receptors in porcine coronary artery--the inhibitory effect of a novel dibenzoxepin derivative, KW-3635.
    Miki I, Ishii A.
    Thromb Haemost; 1992 May 04; 67(5):582-4. PubMed ID: 1387741
    [Abstract] [Full Text] [Related]

  • 7. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH, Woodward DF, Gibson LL, Protzman CE, Williams LS, Burk RM, Gac TS, Roof MB, Abbas F, Marshall K, Senior J.
    Br J Pharmacol; 1996 Mar 04; 117(6):1171-80. PubMed ID: 8882612
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM, Wu TS, Teng CM.
    Br J Pharmacol; 1994 Mar 04; 111(3):906-12. PubMed ID: 8019768
    [Abstract] [Full Text] [Related]

  • 9. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
    Okwu AK, Mais DE, Halushka PV.
    Biochim Biophys Acta; 1994 Mar 10; 1221(1):83-8. PubMed ID: 8130280
    [Abstract] [Full Text] [Related]

  • 10. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S, Nakahata N, Ohizumi Y.
    Br J Pharmacol; 1996 Mar 10; 117(6):1095-104. PubMed ID: 8882602
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D, Wencel-Drake JD, Dieter JP, Lim CT, Le Breton GC.
    Biochem Pharmacol; 1996 Sep 13; 52(5):763-70. PubMed ID: 8765474
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
    Bertolino F, Valentin JP, Maffre M, Grelac F, Bessac AM, Maclouf J, Delhon A, Lévy-Toledano S, Patoiseau JF, Colpaert FC.
    Br J Pharmacol; 1995 May 13; 115(1):210-6. PubMed ID: 7647979
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
    Krauss AH, Woodward DF, Burk RM, Gac TS, Gibson LL, Protzman CE, Abbass F, Marshall K, Senior J.
    J Ocul Pharmacol Ther; 1997 Aug 13; 13(4):303-12. PubMed ID: 9261766
    [Abstract] [Full Text] [Related]

  • 17. AGN 191976: a novel thromboxane A2-mimetic with ocular hypotensive properties.
    Krauss AH, Woodward DF, Chen J, Gibson LL, Lai RK, Protzman CE, Shan T, Williams LS, Gac TS, Burk RM.
    J Ocul Pharmacol Ther; 1995 Aug 13; 11(3):203-12. PubMed ID: 8590251
    [Abstract] [Full Text] [Related]

  • 18. Antagonistic actions of S-145 on vascular and platelet thromboxane A2 receptors.
    Mihara S, Hara S, Ueda M, Ide M, Fujimoto M.
    Eur J Pharmacol; 1989 Nov 21; 171(2-3):179-87. PubMed ID: 2533558
    [Abstract] [Full Text] [Related]

  • 19. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M, Mais DE, Morinelli TA, Hamanaka N, Oatis JE, Halushka PV.
    J Pharmacol Exp Ther; 1992 Aug 21; 262(2):632-7. PubMed ID: 1386885
    [Abstract] [Full Text] [Related]

  • 20. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
    Cozzi P, Giordani A, Menichincheri M, Pillan A, Pinciroli V, Rossi A, Tonani R, Volpi D, Tamburin M, Ferrario R.
    J Med Chem; 1994 Oct 14; 37(21):3588-604. PubMed ID: 7932586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.